MW
Michel Wouters
Also known as: Wouters MW, Michel W Wouters, Wouters MWJM, MWJM Wouters, Wouters Michel W
Leiden University Medical Center, Dutch Institute for Clinical Auditing, The Netherlands Cancer Institute
Research areas: Medicine · Oncology · Cutaneous Melanoma Detection and Management · Cancer Immunotherapy and Biomarkers · Healthcare Quality and Management
0000-0001-6173-0662
Employment
-
Leiden University Medical Center Professor Quality of Cancer Care2020 - Present
-
Dutch Institute for Clinical Auditing Chief Scientific Officer2010 - Present
-
Netherlands Cancer Institute Surgical Oncologist2007 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (265)
- ASO Visual Abstract: The Impact of Best Practice Meetings on Outcomes of Esophageal Cancer Surgery in the Netherlands Save
- Predictive value of [18F]FDG PET/CT and index lymph node response following neoadjuvant pembrolizumab in resectable stage 3 melanoma: Real world data from the largest melanoma centres in the Netherlands Save
- “Numbers call for action, personalized narratives provide support and recognition”: a qualitative assessment of cancer patients’ perspectives on patient-reported outcome measures (PROMs) feedback with narratives Save
- Utilization of Lung Cancer Registries in Learning Health Systems for Health Care Improvement Save
- The European Pediatric Surgical Audit: Improving Quality of Care in Rare Congenital Malformations Save
- Surgical considerations for tumour-infiltrating lymphocyte therapy in melanoma: results from a randomized phase III trial Save
- The Role of [18F]FDG PET/CT Prior to and During Neoadjuvant Chemotherapy for Soft Tissue Sarcomas Save
- Development of a Decision Model to Estimate the Outcomes of Treatment Sequences in Advanced Melanoma Save
- Magnetic seed localization is feasible for non-palpable melanoma, Merkel cell carcinoma, and soft tissue sarcoma lesions Save
- Improvement of perioperative outcomes of gastric gastrointestinal stromal tumour (GIST) resections and the influence of minimal invasive surgery Save
- Adverse Events in Anti-PD-1-Treated Adjuvant and First-Line Advanced Melanoma Patients Save
- The effect of a single dose of nivolumab prior to isolated limb perfusion for patients with in-transit melanoma metastases: An interim analysis of a phase Ib/II randomized double-blind placebo-controlled trial (NivoILP trial) Save
- Assessing quality of hepato-pancreato-biliary surgery: nationwide benchmarking Save
- The Impact of the COVID-19 Pandemic on Time to Treatment in Surgical Oncology: A National Registry Study in The Netherlands Save
- Patient and Staff Experience of Remote Patient Monitoring—What to Measure and How: Systematic Review Save
- Socio‐economic disparities in hospital care among Dutch patients with diabetes mellitus Save
- Use of hospital care among Dutch diabetes patients Save
- IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma Save
- A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors Save
- Patient and Staff Experience of Remote Patient Monitoring—What to Measure and How: Systematic Review (Preprint) Save